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1a,25-dihydroxyvitamin D3 [1,25(OH)2D3] regulates mineral homeostasis and exhibits potent anti-proliferative,
prodifferentiative, and immunomodulatory activities. It mediates these effects by binding to the vitamin D receptor
(VDR), which belongs to the superfamily of steroid/thyroid hormone nuclear receptors. As a result of keratinocyte
differentiation and anti-proliferation activities, 1,25(OH)2D3 and its synthetic analogs are therapeutically effective in
psoriasis and show promise for the treatment of actinic keratosis and squamous cell carcinoma. To elucidate the
VDR signaling pathway in keratinocytes, we examined the gene expression proﬁle with 1,25(OH)2D3 treatment using
oligonucleotide microarrays. Out of the 12,600 genes investigated, 82 were upregulated and 16 were downregulated
and many of these were involved in differentiation, proliferation, and immune response. We have identiﬁed three
vitamin D-responsive chromosomal loci (1p36, 19q13, and 6p25) and show the induction of various class II tumor
suppressor/growth-regulatory genes in response to 1,25(OH)2D3. Finally, quantitative differences in gene expres-
sion revealed a vitamin D-regulated differentiation network and identiﬁed peptidylarginine deiminases, kallikreins,
serine proteinase inhibitor family members, Kruppel-like factor 4, and c-fos as vitamin D-responsive genes, whose
protein products may play an important role in epidermal differentiation in normal and diseased state.
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Biological actions of the hormonally active form of vitamin
D3, 1,25-dihydroxyvitamin D3 [1,25(OH)2D3], and its syn-
thetic analogs are mediated by the vitamin D receptor
(VDR). VDR, a ligand-dependent transcription factor be-
longing to the superfamily of steroid/thyroid hormone re-
ceptor, regulates gene expression as a heterodimer with
retinoid X receptor (RXR). Ligand occupancy of the VDR
ligand binding domain in RXR–VDR heterodimer leads to
the recruitment of chromatin remodeling complexes and
coactivators to the responsive promoters, resulting in the
assembly of transcription initiation complex and vitamin D-
mediated induction of gene expression (Rachez et al, 2000).
VDR has traditionally been linked with calcemic activities,
namely, calcium and phosphorus homeostasis, and main-
tenance of bone health and architecture. But the presence
of VDR in cells other than those of the intestine, bone, kid-
ney, and parathyroid gland led to the recognition of non-
calcemic actions of VDR ligands (Pinette et al, 2003). As a
result, 1,25(OH)2D3 and its synthetic analogs exhibit differ-
entiation, anti-proliferation, and immunomodulatory activi-
ties, and they show therapeutic efficacy in skin diseases
involving defective keratinocyte differentiation, such as pso-
riasis, seborhheic dermatitis, and ichthyosis (Pinette et al,
2003). Promotion of epithelial differentiation by VDR ligands
also provides a mechanistic basis for their potential use in
the treatment of actinic keratosis, head and neck squamous
cell carcinoma (HNSCC), and basal cell carcinoma. Psoria-
sis, a chronic inflammatory skin disease, is characterized by
keratinocyte hyperproliferation and abnormal differentiation.
Although natural (calcitriol) and synthetic (calcipotriol) VDR
ligands are used in clinic for the treatment of psoriasis (Pi-
nette et al, 2003), molecular events leading to the normal-
ization of keratinocyte differentiation by VDR ligands have
not been fully explored. A molecular understanding of vita-
min D-mediated keratinocyte differentiation is an important
step in delineating the mechanism of action of VDR ligands
in dermal indications and it may also yield biomarkers of
efficacy and molecular screens for the identification of VDR
modulators with increased therapeutic indices.
In an effort to understand the VDR signaling pathway in
keratinocytes more comprehensively, we have discovered a
vitamin D-regulated differentiation network in which most of
the 1,25(OH)2D3-responsive genes have not been reported
previously. Further, we have identified three 1,25(OH)2D3-
responsive chromosomal loci, where peptidylarginine dei-
minase (PADI), kallikrein (KLK), and serine proteinase inhib-
itor (SERPIN B) gene family members show vitamin D-
dependent expression in both immortalized (KerTr) and
primary normal human epidermal keratinocytes (NHEK). We
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sulin-like growth factor binding protein; KLF4, Kruppel like factor 4;
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also show that 1,25(OH)2D3 regulates the expression of
genes required for the formation of cornified envelope
and desquamation, processes that show abnormalities in
psoriatic lesions. These genes could be functionally inte-
grated into a vitamin D-responsive network based upon
the roles their protein products play in the processes of
keratinocyte proliferation, cornified envelope formation,
desquamation, and epidermal homeostasis. Further, we
demonstrate that 1,25(OH)2D3 induces the expression of a
number of class II tumor suppressor and growth-regulatory
genes. These results not only provide a plausible molecular
basis of the therapeutic action of VDR ligands in psoriasis
but also an insight into their mechanism of action in
squamous cell carcinomas.
Results
1,25(OH)2D3 inhibits the proliferation of keratinocytes and
increases their differentiation in vitro and in vivo (Bikle et al,
2003). To elucidate the molecular mechanisms underlying
vitamin D-mediated differentiation and anti-proliferative ac-
tivity, a global picture of 1,25(OH)2D3-mediated gene ex-
pression in proliferating keratinocytes was determined by
interrogating the Affymetrix GeneChips containing 12,600
genes with mock-treated and 1,25(OH)2D3-treated keratin-
ocytes. KerTr cells were treated for 0, 6, 24, and 48 h with
1,25(OH)2D3 (10
7 M) in three independent experiments.
The response to 1,25(OH)2D3 was verified by Taqman quan-
titative PCR (Q-PCR) analysis of 24-hydroxylase gene
expression. For microarray screening, RNA from each
independent experiment at a given time point was interro-
gated with duplicate gene chips. Therefore, six gene chips
were used for expression profiling at each time point. Dif-
ferentially expressed genes were identified based on a
combination of fold changes (42.0) and t test (po0.05), and
data were filtered to eliminate genes because of inconsist-
ent expression across the chip replicates. We identified 98
genes (82 upregulated and 16 downregulated) that were
reproducibly regulated by 1,25(OH)2D3 (Supplemental data).
Q-PCR on a limited number of these genes confirmed the
changes in their expression in independent proliferating
keratinocyte cultures. The results indicate that the VDR
signaling in keratinocytes affects many cell functions
that ultimately explain at least in part, the differentiation,
anti-proliferative, and immunomodulatory activities of
1,25(OH)2D3.
Identiﬁcation of PADI family members as vitamin D-re-
sponsive genes PADI is a family of Ca2þ -dependent en-
zymes that catalyze the post-translational deimination of
arginine residues to citrullines. The terminally differentiated
cornified layer of the epidermis contains deiminated kera-
tins (K1, K10, K14, and K5) and filaggrin (Ohsawa et al,
1999; Ishida-Yamamoto et al, 2000), thus suggesting a role
for protein deimination during the final stages of epidermal
differentiation. The degree of modification of arginines to
citrulline residues directly correlates with the structural or-
der of substrate (Tarcsa et al, 1996). Therefore, the PADI
family of enzymes is proposed in protein unfolding as dis-
ordered structure of cornified envelope component proteins
is required for optimal interaction with intermediary fila-
ments and transglutaminase I (TGase I) (Tarcsa et al, 1996).
There are four PADI genes in humans, namely PADI 1, PADI
2, PADI 3, and PADI 4, and of these PADI 1 and PADI 3 have
shown to be expressed in the epidermis (Nakashima et al,
2002). The expression of PADI 3 was strongly induced by
1,25(OH)2D3 treatment at 24 and 48 h time points (Supple-
mental data). The regulation of PADI 3 was confirmed by Q-
PCR, and its expression was found to be upregulated by 6,
24, and 48 h treatment of keratinocytes with the VDR ligand
(Fig 1A). As the PADI family of genes is clustered on chro-
mosome 1p36 in humans, we next analyzed the expression
of PADI 1 and PADI 2 in 1,25(OH)2D3-treated keratinocytes
by Q-PCR. PADI 1 and PADI 2 gene expression was also
induced after 6, 24, and 48 h treatment of keratinocytes with
1,25(OH)2D3 (Fig 1A). In NHEK, induction of the expression
of PADI 1, 2, and 3 genes was observed after 6 h treatment
with 1,25(OH)2D3 (Fig 1A).
Identiﬁcation of KLK family members as vitamin D-re-
sponsive genes Proliferation of keratinocytes to terminally
differentiated corneocytes is balanced by the shedding of
old corneocytes at the stratum corneum. This process of
desquamation is achieved physiologically by tissue KLK,
which constitute a group of serine proteases encoded by
clusters of 15 genes on chromosome 19q13.3–4 (Komatsu
et al, 2003). Microarrays identified KLK5, KLK6, and KLK10
as vitamin D-responsive genes (Supplemental data). The
expression of another KLK family member, KLK8, was also
induced by 1,25(OH)2D3 at 48 h (1.8-fold induction), but it
fell through the filtering process because of theX2-fold cut-
off for retaining differentially expressed genes. 1,25(OH)2D3
induced the expression of KLK5, KLK6, KLK7, KLK8,
KLK10, and KLK13 in KerTr as well as in NHEK cells (Fig
1B). The expression of KLK5, KLK6, KLK10, and KLK13 was
induced after 6, 24, and 48 h of treatment in KerTr cells,
whereas that of KLK8 was induced at 24 and 48 h but not at
6 h. Significant vitamin D-mediated expression of KLK7 was
observed only at 24 h time point in KerTr cells (Fig 1B). But
in NHEK, 1,25(OH)2D3 induced the expression of KLK5,
KLK6, KLK7, KLK8, KLK10, and KLK13 after 6 h of ligand
treatment (Fig 1B). KLK11 expression was not regulated by
the VDR ligand (data not shown). The expression of another
serine protease, HtrA1 (encoded by protease serine (PRSS)
11 gene), was also induced by 1,25(OH)2D3 (Supplemental
data).
Vitamin D-mediated induction of the expression of
serine proteinase inhibitor gene family members Micro-
array analysis showed that the expression of serine pro-
teinase inhibitors SERPIN B1 and SERPIN B6 was induced
in keratinocytes by 1,25(OH)2D3 treatment (Supplemental
data). SERPIN B1 expression was induced by 6-, 19-, and
19-fold, respectively, by 6, 24, and 48 h treatment with the
VDR ligand. SERPIN B6 induction (3-fold) was observed
only at 48 h time point (Supplemental data). Serine protein-
ase inhibitor activity in the corneocytes has been proposed
to be important for negative feedback regulation of stratum
corneum serine protease activity (Komatsu et al, 2003). The
13 human ov-serpin genes are clustered at 6p25 (three
genes, namely SERPIN B1, SERPIN B6, and SERPIN
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B9) and 18q21 (10 genes). By Q-PCR, the expression of
SERPIN B1, SERPIN B6, and SERPIN B9 was found to be
increased in KerTr cells by 6, 24, and 48 h of treatment by
the VDR ligand (Fig 1C). The expression of the SERPIN
genes was also upregulated by 6 h exposure of NHEK to
1,25(OH)2D3 (Fig 1C).
Identiﬁcation of vitamin D-regulated genes involved
in keratinocyte terminal differentiation Expression of a
number of genes that are involved in terminal differentiation
of keratinocytes was modulated by 1,25(OH)2D3 treatment.
These genes include involucrin, cystatin EM, small-proline-
rich protein 1B (SPRR1B), TGase I, Kruppel-like factor 4
(KLF4), and c-fos (Supplemental data and Fig 2). In mic-
roarrays, involucrin expression was increased by 1.5-fold
after 48 h of 1,25(OH)2D3 treatment (data not shown). Q-
PCR results, however, showed significant induction of in-
volucrin expression after 6, 24, and 48 h of 1,25(OH)2D3
treatment in KerTr and 6 h in NHEK cells (Fig 2A). Another
differentiation-specific protein, cystatin EM, a component of
the cornified envelope (Zeeuwen et al, 2001), showed a vi-
tamin D-dependent induction in its expression at all the
three time points analyzed in KerTr cells and after 6 h of
treatment in NHEK (Supplemental data and Fig 2A). Micro-
array results indicated downregulation of SPRR1B after 6 h
treatment of keratinocytes with 1,25(OH)2D3 (Supplemental
data). This observation was confirmed by Q-PCR, where 6 h
treatment of KerTr cells with 1,25(OH)2D3 led to a suppres-
sion of SPRR1B expression (Fig 2B). Epithelial enriched
transcription factor, KLF4, is highly expressed in the differ-
entiating layers of epidermis and it is required for estab-
lishing epidermal permeability barrier (Segre et al, 1999;
Jaubert et al, 2003). KLF4 showed 1,25(OH)2D3-dependent
induction in its expression in KerTr and NHEK cells (Fig 2B).
In microarrays, the expression of fos gene was induced 10-,
10-, and 4-fold, respectively, after 6, 24, and 48 h treatment
Figure 1
1a, 25-dihydroxyvitamin D3 (1,25(OH)2D3)-dependent regulation of the expression of peptidylarginine deiminase (PADI), kallikrein (KLK), and
serine proteinase inhibitor (SERPIN B) family members. (A–C). Taqman quantitative PCR was performed on total RNA prepared from vehicle-
treated KerTr cells (red bars) and cells treated for 6, 24, and 48 h with 1,25(OH)2D3 (blue bars). RNA was also prepared from vehicle-treated normal
human epidermal keratinocyte (NHEK) cells (red bars) and cells treated 6 h (blue bars) with 1,25(OH)2D3. The amount of PADI 1, PADI 2, and PADI 3
(A), KLK 5, KLK6, KLK7, KLK8, KLK10, and KLK13 (B), and SERPIN B1, SERPIN B6, and SERPIN B9 (C) gene transcripts relative to the glycer-
aldehyde-3-phosphate dehydrogenase transcript is shown as mean  SE of triplicate experiments.
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(Supplemental data). Vitamin D-mediated regulation of c-fos
expression was confirmed by Q-PCR, where 6 h treatment
of KerTr and NHEK showed 3–5-fold induction in its ex-
pression. Its expression was also induced at 24 and 48 h
time points in KerTr cells (Fig 2C).
Regulation of class II tumor suppressor/growth-regula-
tory and immunomodulatory genes by 1,25(OH)2D3 VDR
ligand induced the expression of class II tumor suppres-
sors PRSS 11, cystatin EM, KLK10, lysyl oxidase (LOX),
thrombomodulin, semaphorin 3B, thrombospondin, and
tazarotene-induced gene 1 (TIG1)/retinoic acid receptor re-
sponsive gene 1 (RARRES1) in keratinocytes (Supplemental
data, Figs 1B and 2D). 1,25(OH)2D3 also induced the ex-
pression of growth-regulatory/cell cycle control genes dual
specificity phosphatase 10 (DUSP-10), insulin-like growth
factor binding protein-3 (IGFBP)-3, and IGFBP-6 in keratin-
ocytes (Supplemental data and Fig 2D).
Keratinocytes, the first line of defense against invading
microbes, are considered to be part of the immune system.
1,25(OH)2D3 induced the expression of monocyte/macroph-
age differentiation marker CD14, and lipopolysaccharide-
binding protein CAP18, highlighting the role of keratinocytes
in innate immunity. CD14 has previously been described
Figure 2
Taqman quantitative PCR (Q-PCR) analysis of a, 25-dihydroxyvitamin D3 (1,25(OH)2D3)-regulated genes in immortalized and normal ker-
atinocytes. (A–D) Q-PCR was performed on total RNA prepared from vehicle-treated KerTr cells (red bars) and cells treated for 6, 24, and 48 h with
1,25(OH)2D3 (blue bars). RNA was also prepared from vehicle-treated normal human epidermal keratinocytes (NHEK) cells (red bars) and cells
treated for 6 h (blue bars) with 1,25(OH)2D3. The amount of involucrin and Cystatin EM (A), small-proline proline-rich protein 1B (SPRR1B),
transglutaminase I (TGase I) (two independent RNA samples after 6 h 1,25(OH)2D3 treatment) and Kruppel-like factor 4 (KLF4) (B), c-fos and T1/ST2
(C) and tazarotene-induced gene 1 (TIG1), insulin-like growth factor binding protein-3 (IGFBP-3) and dual specificity phosphatase-10 (DUSP-10)
gene transcripts relative to the glyceraldehyde-3-phosphate dehydrogenase transcript is shown as mean  SE of triplicate experiments. (E).
Schematic representation of vitamin D-responsive chromosomal loci. A diagrammatic representation of peptidylarginine deiminase (PADI), kallikrein
(KLK), and serine proteinase inhibitor family members at 1p36, 19q13, and 6p25 chromosomal loci, respectively, in humans is shown. Arrows
indicate the direction of transcription of genes.
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as a vitamin D-responsive gene in HL-60 promyelocytic
leukemic and SCC25 cells (Rots et al, 1998; Lin et al, 2002).
The expression of IL1 receptor like 1 (IL1RL1; T1/ST2) gene
was induced by 1,25(OH)2D3 in keratinocytes (Supplemen-
tal data and Fig 2C) and SCC 25 cells (Lin et al, 2002). As
IL1RL1 gene disruption leads to a defect in T-helper type 2
(Th2) differentiation (Townsend et al, 2000), vitamin D-me-
diated induction of its expression suggests that the shift of
balance from pathogenic Th1 (IL-2-, IFN-g-, and TNF-a-
secreting T cells) to non-pathogenic Th2 (IL-4-, IL-5-, and
IL-10-producing T cells) phenotype in psoriasis by VDR
ligands may involve a direct role of keratinocytes in Th2
differentiation.
Discussion
In this study, by gene expression profiling of 1,25(OH)2D3-
treated keratinocytes, we demonstrate that PADI, KLK, and
SERPIN B family members are vitamin D-responsive genes.
We further identify a vitamin D-regulated differentiation net-
work that provides a plausible mechanism of therapeutic
action of VDR ligands in psoriasis and squamous cell car-
cinoma.
Identiﬁcation of a vitamin D-regulated keratinocyte ter-
minal differentiation network Expression profiling and Q-
PCR results could be distilled into a vitamin D-mediated
keratinocyte/epidermal differentiation network, wherein
many of the components were identified for the first time
as vitamin D-responsive genes (Fig 3). The network involves
seven major nodes or components that are directly regu-
lated by the VDR ligand. These components are: (1) cross-
linked proteins that give rise to the cornified envelope; (2)
PADI family of enzymes; (3) TGase I, the enzyme that cross-
links substrates to form the cornified envelope; (4) KLK
family of serine proteases; (5) SERPIN B family members; (6)
KLF4; and (7) c-fos (Fig 3). The first component (node) of
this network comprises cross-linked proteins, namely in-
volucrin, cystatin EM, and SPRR1B (Fig 2A and B, Fig 3 and
Supplemental data). Involucrin, a major component of the
cross-linked envelope (Eckert et al, 2004), is vitamin D-re-
sponsive and contains a VDRE in its promoter (Bikle et al,
2003). Q-PCR results showed significant induction of in-
volucrin expression after 1,25(OH)2D3 treatment in keratin-
ocytes (Fig 2A). Another differentiation-specific protein,
cystatin EM, also a component of the cornified envelope
that is highly expressed in differentiated epidermis (Zeeu-
wen et al, 2001), showed a vitamin D-dependent induction
in its expression at all the three time points analyzed (Sup-
plemental data and Fig 2A). Expression profiling of an
HNSCC cell line also showed induction of cystatin EM by a
synthetic vitamin D analog EB1089 (Lin et al, 2002). Impor-
tantly, microarray results indicated downregulation of small
proline-rich protein, SPRR1B expression (Table S1 and Fig
3B). The expression of SPRR1B protein is increased signif-
icantly in psoriasis (Koizumi et al, 1996) and it may con-
tribute to abnormal keratinocyte differentiation in psoriatic
lesional skin. Therefore, potent inhibition of SPRRIB ex-
pression by 1,25(OH)2D3 may contribute toward normaliza-
tion of keratinocyte differentiation observed by VDR ligands
in psoriatic skin.
The expression of PADI family members, the second
node of the differentiation network, was upregulated by the
VDR ligand in KerTr and NHEK cells (Fig 1A). PADI family
members facilitate unfolding of ordered a-helical structure
of proteins that are then cross-linked by TGase I (Fig 3). The
induction of the expression of PADI gene family members
by 1,25(OH)2D3 appears to be therapeutically relevant in
psoriasis, because immunostaining based on citrulline res-
idues revealed that the normal and uninvolved psoriatic
epidermis contained deiminated proteins in the terminally
differentiated cornified layers, whereas lesional psoriatic
epidermis presented with strikingly reduced levels of dei-
minated proteins (Ishida-Yamamoto et al, 2000). Thus, VDR
ligands may improve the underlying pathology of psoriasis
by inducing the expression of PADI gene family members.
Basal-level expression of PADI genes was higher in NHEK
than KerTr cells (Fig 1A), suggesting that immortalization
leads to suppression of PADI gene expression. Further,
Figure 3
Vitamin D-regulated differentiation
network. 1a, 25-dihydroxyvitamin D3
(1,25(OH)2D3)-regulated genes identified
by microarrays and Taqman quantitative-
PCR analysis were arranged in the form of
a network based upon their function and
action on keratinocyte/epidermal differen-
tiation in normal and/or psoriatic states.
The network consists of seven nodes
(shown as colored circles), where each
node is represented by a group of vitamin
D-regulated genes. The seven nodes are
as follows: cornified envelope proteins,
peptidylarginine deiminase (PADI) family
members, transglutaminase I (TGase I),
kallikrein (KLK) family members, serine
proteinase inhibitor (SERPIN) B family
members, Kruppel-like factor (KLF)4,
and c-fos.
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another anti-psoriatic agent, retinoic acid, which normalizes
keratinocyte differentiation, induced PADI enzymatic activity
in primary rat keratinocytes (Ishigami et al, 1996).
The expression of TGase I, the third component of the
network, is increased in psoriatic lesional skin (Nonomura
et al, 1993). TGase I mediates cross-linking of structural
proteins into the cornified envelope by promoting the for-
mation of interprotein g-glutamyl-lysine isopeptide bonds.
Therefore, increased TGase I expression may result in ab-
normal/psoriatic differentiation and may contribute to the
formation of excess cornified scales characteristics of pso-
riasis. It may actively cross-link abnormally expressed
proteins (e.g., SPRR family members, myeloid-related
protein-8 (MRP-8), skin-derived anti-leukoproteinase
(SKALP), psoriasin, etc.) at the expense of normal cornified
envelope components in psoriatic epidermis, which may
affect the quality of the epidermis (Nagpal et al, 1996b).
Treatment of proliferating keratinocytes with the VDR ligand
decreased the expression of TGase I (Fig 2B). It is note-
worthy that another keratinocyte differentiation-promoting
agent, tazarotene, a retinoic acid receptor b/g-selective re-
tinoid that is used in clinic for the treatment of psoriasis,
inhibited TGase I expression in psoriatic lesions (Nagpal
et al, 1996b).
The fourth node of the differentiation network is the KLK
family of enzymes, whose expression is induced by the VDR
ligand in KerTr and NHEK cells (Fig 1B). The topmost corni-
fied layers of skin are constantly removed by the action of
the KLK family of serine proteases. Desquamation by KLK
present in the stratum corneum results by their ability to
degrade corneodesmosin and desmoglein-1, components
of corneodesmosomes (Suzuki et al, 1996; Simon et al,
2001; Komatsu et al, 2003). KLK5, KLK6, and KLK8 have
been reported to be expressed in corneocytes (Komatsu
et al, 2003). Abnormal differentiation, hyperproliferation, and
low rate of desquamation is believed to be the cause for
build-up of scales observed in psoriatic lesional skin. Vita-
min D-mediated induction of the expression of KLK family
members provides a molecular basis for the clinical action
of topically applied VDR ligand calcitriol (1,25(OH)2D3) in
plaque-type psoriasis, as the drug treatment results in rapid
desquamation leading to decreased plaque thickness
(Smith et al, 1988).
The fifth component of this network is the family of serine
protease inhibitors (SERPIN B1, SERPIN B6, and SERPIN
B9), whose expression was induced by 1,25(OH)2D3 prob-
ably to balance the equilibrium between terminal differen-
tiation and desquamation, by virtue of their ability to inhibit
the activity of KLK (Komatsu et al, 2003). Genetic defect of a
serine protease inhibitor, serine protease inhibitor Kazal-
type 5, presents with overdesquamation, aberrant hair
growth, and temperature instability in the Netherton syn-
drome (Chavanas et al, 2000).
The sixth component, KLF4, which showed vitamin D-
dependent regulation in keratinocytes (Fig 2B), inhibits cell
proliferation by blocking G1/S transition of the cell cycle
(Chen et al, 2001). KLF4 gene ablation studies have under-
scored its importance in epidermal differentiation and for
establishing barrier function of the skin (Segre et al, 1999).
Transcriptional profiling of KLF4 revealed that a large
number of genes encoded keratins, further indicating the
importance of KLF4 in epithelial differentiation (Chen et al,
2003).
The expression of c-fos, the seventh node in this net-
work, was induced by 1,25(OH)2D3 treatment in keratin-
ocytes (Fig 3C). Activator protein 1 (AP1), a complex of
transcription factors c-jun and c-fos, regulates the tran-
scription of a number of genes that are involved in keratin-
ocyte differentiation. In addition, all the treatments that
induce AP1 activity and c-fos expression also result in ker-
atinocyte differentiation (Johansen et al, 2003; Eckert et al,
2004; Schmuth et al, 2004). Further, c-fos expression is re-
duced in psoriatic lesional skin compared with normal ep-
idermis (Basset-Seguin et al, 1991). Therefore, induction of
c-fos by 1,25(OH)2D3 may help in normalization of differen-
tiation observed by the treatment of psoriatic lesions by
VDR ligands.
Vitamin D-dependent regulation of growth regulatory
genes Expression of a number of growth-regulatory or class II
tumor suppressor genes was induced by 1,25(OH)2D3.
These genes are PRSS 11, cystatin EM, KLK10, LOX,
thrombomodulin, semaphorin 3B, thrombospondin, TIG1,
DUSP-10, IGFBP-3, and IGFBP-6. Expression of PRSS 11
is reduced in tumors and its transfection into cancer
cells inhibited their growth in vitro and in vivo (Baldi et al,
2002). Cystatin EM, whose expression was induced by
1,25(OH)2D3 in keratinocytes (Fig 2A), also showed VDR
ligand-dependent upregulation in an HNSCC cell line,
SCC25 (Lin et al, 2002). Cystatin EM was expressed in nor-
mal and premalignant breast epithelial cells but not in met-
astatic breast cancer cells (Sotiropoulou et al, 1997) and its
overexpression suppressed the malignant phenotype of a
highly tumorigenic breast cancer cell line (Shridhar et al,
2004). KLK10 functions as a class II tumor suppressor in
breast and testicular tissues (Luo et al, 2001; Yousef et al,
2004). The expression of KLK10 was also induced by
1,25(OH)2D3 and its synthetic analog EB1089 in SCC25
cells (Lin et al, 2002). LOX has shown tumor suppressor
functions in vitro and in vivo. Its expression was reduced in
HNSCC cell lines, mucocutaneus malignant tissues, colo-
rectal tumors and its overexpression led to reduced breast
cancer cell invasion (Csiszar et al, 2002; Kirschmann et al,
2002; Jeay et al, 2003; Rost et al, 2003). Thrombomodulin,
the thrombin receptor, exerted growth suppressor effect
and its expression inversely correlated with tumor progres-
sion in humans (Tezuka et al, 1995). Semaphorin 3B, which
is expressed at reduced levels in both small-cell and
non-small-cell lung carcinomas, suppressed tumor forma-
tion in vivo (Tse et al, 2002). TIG1/RARRES1, originally
identified as a retinoid responsive gene (Nagpal et al,
1996a), showed 1,25(OH)2D3-dependent induction in
KerTr cells (Fig 2D). TIG1 was found to be a class II tumor
suppressor in prostate carcinoma (Jing et al, 2002; Lotan,
2002). DUSP-10 and IGFBP-3 have previously been shown
to be responsive to 1,25(OH)2D3 in prostate cancer cells
(Krishnan et al, 2003). DUSP-10 inactivates mitogen-acti-
vated protein kinase (MAPK), indicating that inhibition of the
growth-promoting actions of MAPK may partly explain the
growth-inhibitory actions of 1,25(OH)2D3 in epithelial cells.
Induction of IGFBP may inhibit the mitogenic effects of IGF
on epithelial cells. Further, the expression of IGFBP-3 was
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found to be obligatory for the growth-inhibitory actions of
1,25(OH)2D3 in prostate cancer cells (Peng et al, 2004).
IGFBP-6 is highly expressed in normal prostate and it
showed downregulation in malignant prostate (Welsh et al,
2001). Therefore, VDR ligands may exert anti-proliferative
effects by inducing the expression of the above-mentioned
class II tumor suppressor and growth-regulatory genes.
Identiﬁcation of vitamin D-responsive chromosomal lo-
ci Human chromosomal region 1q21 contains an epidermal
differentiation locus that harbors genes required for kera-
tinocyte differentiation (Marshall et al, 2001). Here, we de-
scribe the identification of three vitamin D-responsive loci at
1p36 (PADI genes), 19q13 (KLK genes), and 6p25 (SERPIN
B genes), that appear to be involved in both normal and
vitamin D-induced epidermal differentiation (Fig 2E). To the
best of our knowledge, these are the only vitamin D-re-
sponsive loci described to date. The induction of gene ex-
pression at these loci may at least in part explain the
mechanism underlying the normalization of differentiation
observed by the treatment of psoriatic plaques by VDR lig-
ands. These results, along with the observations docu-
menting common occurrence of the loss of heterozygosity
at 1p36.1 in cutaneous malignancies (Araki et al, 2002),
highlight the therapeutic potential of VDR ligands in actinic
keratosis, HNSCC, basal cell carcinoma, and melanoma.
The vitamin D-dependent epidermal differentiation network
may operate not only in pathogenic but also under normal
conditions. VDR null animals showed increased epidermal
thickness and keratinocyte proliferation beginning at 7 wk
of age (Zinser et al, 2002), indicating a keratinocyte dif-
ferentiation defect that is not compensated by retinoic
acid receptors, peroxisome proliferator-activated receptors,
farnesoid X receptors, and liver X receptors. Finally, the
presence of skin differentiation defect and epidermal hyper-
proliferation in keratinocyte-specific RXRa and RXRa/RXRb
compound null animals (Li et al, 2000) further supports this
notion, and suggests that apart from normalization of dif-
ferentiation in pathogenic conditions, VDR may also play an
important role in normal epidermal differentiation.
Materials and Methods
Cells, RNA isolation, and microarray analysis HPV E6 and E7
immortalized keratinocyte cell line, KerTr (ATCC), was grown in
serum-free keratinocyte growth medium (KGM) (Life Technologies,
Rockville, Maryland) supplemented with 0.05 mg per mL bovine
pituitary extract (BPE) and 35 ng per mL epidermal growth factor
(EGF). NHEK (Bio Whittaker, Walkersville, Maryland) were cultured
in KGM supplemented with BPE, EGF, Insulin, GA-1000 (gent-
amicin, amphotericin B), and hydrocortisone (KGM-BulletKit, Bio
Whittaker, Walkersville, Maryland). KerTr cells were treated with
DMSO (vehicle) or 1,25(OH)2D3 (10
7 M) for 6, 24, and 48 h in three
independent experiments. NHEK were treated with DMSO (vehicle)
or 1,25(OH)2D3 (10
7 M) for 6 h. Total RNA was isolated with TRIzol
(Life Technologies). Complementary DNA (cDNA) was synthesized
by the SuperScript First-Strand Synthesis System for RT-PCR (Life
Technologies). For microarrays, 5 mg of total RNA was labeled ac-
cording to the Affymetrix protocol (Affymetrix, Santa Clara, Cali-
fornia). Twenty micrograms of labeled cRNA was fragmented and
mixed with hybridization controls. This hybridization cocktail was
hybridized to duplicate Affymetrix HG-U133A GeneChips for 16 h
at 451C. After hybridization, the chips were washed and scanned
on an Affymetrix GeneChip scanner, and analyzed with Microarray
Suite version 5.0 (MAS5, Affymetrix).
Data analysis Signal intensities were generated from Microarray
Suite version 5.0 (MAS5), using the default settings, and a global
scaling, which adjusts the trimmed mean signal for the entire chip
to a value of 1500. MAS5 generates quantitative data for single
arrays and can perform a pair-wise comparison of two arrays. But
in order to apply statistical analysis to the experiment, for each
probeset, the fold-change was calculated as the ratio of the two
group means based on the observed signal values from MAS5 for
the two treatment groups. At the same time, the hypothesis of no
differential expression was tested for each individual probeset us-
ing t-statistics.
Q-PCR Selected genes identified by microarrays were verified by
Q-PCR using an ABI PRISM 7900HT Sequence Detection System
(Applied Biosystems, Foster City, California). Primers and probes
for some genes (KLK10, c-fos, SERPIN B1, involucrin, KLK6,
KLK7, KLK8, and KLK10) were designed using Primer Express
software (Applied Biosystems). These sequences are available
upon request. Probes were labeled with fluorescent reporter dye
FAM at the 50-end and quencher dye TAMRA (Applied Biosystems,
Foster City, California) at the 30-end. For other genes, optimized
primer and probes sets were obtained commercially (Applied Bio-
systems). Each 20 mL reaction consisted of forward and reverse
primers (900 nM), TaqMan probe (200 nM), cDNA (prepared from 8
ng of total RNA), and TaqMan Universal PCR Master Mix (Roche
Diagnostics, Indianapolis, Indiana). Reactions were incubated at
501C for 2 min followed by 10 min at 951C, and subjected to 40
cycles of PCR (951C for 15 s followed by 601C for 1 min). Glycer-
aldehyde-3-phosphate dehydrogenase was used as an internal
control and its primer and probe set were obtained commercially
(Applied Biosystems).
Supplementary Material
The following material is available from http://www.blackwellpublishing.
com/products/journals/suppmat/JID/JID23641/JID23641sm.htm
Table S1. Vitamin D-regulated genes in proliferating keratinocytes.
DOI: 10.1111/j.0022-202X.2005.23641.x
Manuscript received July 7, 2004; revised October 5, 2004; accepted
for publication November 9, 2004
Address correspondence to: Sunil Nagpal, Bone and Inflammation
Research, Eli Lilly & Company, Indianapolis, Indiana 46285, USA.
Email: NAGPAL_SUNIL@LILLY.COM
References
Araki D, Uzawa K, Watanabe T, Shiiba M, Miyakawa A, Yokoe H, Tanzawa H:
Frequent allelic losses on the short arm of chromosome 1 and decreased
expression of the p73 gene at 1p36.3 in squamous cell carcinoma of the
oral cavity. Int J Oncol 20:355–360, 2002
Baldi A, De Luca A, Morini M, et al: The HtrA1 serine protease is down-regulated
during human melanoma progression and represses growth of metastatic
melanoma cells. Oncogene 21:6684–6688, 2002
Basset-Seguin N, Escot C, Moles JP, Blanchard JM, Kerai C, Guilhou JJ: C-fos
and c-jun proto-oncogene expression is decreased in psoriasis: An in situ
quantitative analysis. J Invest Dermatol 97:672–678, 1991
Bikle DD, Tu CL, Xie Z, Oda Y: Vitamin D regulated keratinocyte differentiation:
Role of coactivators. J Cell Biochem 88:290–295, 2003
Chavanas S, Bodemer C, Rochat A, et al: Mutations in SPINK5, encoding a serine
protease inhibitor, cause Netherton syndrome. Nat Genet 25:141–142,
2000
Chen X, Johns DC, Geiman DE, et al: Kruppel-like factor 4 (gut-enriched Kruppel-
like factor) inhibits cell proliferation by blocking G1/S progression of the
cell cycle. J Biol Chem 276:30423–30428, 2001
784 LU ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Chen X, Whitney EM, Gao SY, Yang VW: Transcriptional profiling of Kruppel-like
factor 4 reveals a function in cell cycle regulation and epithelial differen-
tiation. J Mol Biol 326:665–677, 2003
Csiszar K, Fong SF, Ujfalusi A, Krawetz SA, Salvati EP, Mackenzie JW, Boyd CD:
Somatic mutations of the lysyl oxidase gene on chromosome 5q23.1 in
colorectal tumors. Int J Cancer 97:636–642, 2002
Eckert RL, Crish JF, Efimova T, et al: Regulation of involucrin gene expression.
J Invest Dermatol 123:13–22, 2004
Ishida-Yamamoto A, Senshu T, Takahashi H, Akiyama K, Nomura K, Iizuka H:
Decreased deiminated keratin K1 in psoriatic hyperproliferative epider-
mis. J Invest Dermatol 114:701–705, 2000
Ishigami A, Ohsawa T, Watanabe K, Senshu T: All-trans retinoic acid increases
peptidylarginine deiminases in a newborn rat keratinocyte cell line. Bioc-
hem Biophys Res Commun 223:299–303, 1996
Jaubert J, Cheng J, Segre JA: Ectopic expression of Kruppel like factor (Klf4)
accelerates formation of the epidermal permeability barrier. Development
130:2767–2777, 2003
Jeay S, Pianetti S, Kagan HM, Sonenshein GE: Lysyl oxidase inhibits ras-me-
diated transformation by preventing activation of NF-kappa B. Mol Cell
Biol 23:2251–2263, 2003
Jing C, El-Ghany M, Beesley C, Foster CS, Rudland PS, Smith P, Ke Y:
Tazarotene-induced gene 1 (TIG1) expression in prostate carcinoma
and its relationship to tumorigenicity. J Natl Cancer Inst 94:482–490,
2002
Johansen C, Kragballe K, Henningsen J, Westergaard M, Kristiansen K, Iversen L:
1a,25-dihydroxyvitamin D3 stimulates activator protein 1 DNA-binding
activity by a phosphoinositol 3-kinase/Ras/MEK/extracellular signal reg-
ulated kinase 1/2 and c-jun N-terminal kinase 1-dependent increase in c-
fos, fra1, and c-jun expression in human keratinocytes. J Invest Dermatol
120:561–570, 2003
Kirschmann DA, Seftor EA, Fong SF, et al: A molecular role for lysyl oxidase in
breast cancer invasion. Cancer Res 62:4478–4483, 2002
Koizumi H, Kartasova T, Tanaka H, Ohkawara A, Kuroki T: Differentiation-asso-
ciated localization of small proline-rich protein in normal and diseased
human skin. Br J Dermatol 134:686–692, 1996
Komatsu N, Takata M, Otsuki N, Toyama T, Ohka R, Takehara K, Saijoh K: Ex-
pression and localization of tissue kallikrein mRNAs in human epidermis
and appendages. J Invest Dermatol 121:542–549, 2003
Krishnan AV, Peehl DM, Feldman D: Inhibition of prostate cancer growth by
vitamin D: Regulation of target gene expression. J Cell Biochem 88:
363–371, 2003
Li M, Indra AK, Warot X, et al: Skin abnormalities generated by temporally con-
trolled RXRalpha mutations in mouse epidermis. Nature 407:633–636,
2000
Lin R, Nagai Y, Sladek R, et al: Expression profiling in squamous carcinoma cells
reveals pleiotropic effects of vitamin D3 analog EB1089 signaling on cell
proliferation, differentiation, and immune system regulation. Mol End-
ocrinol 16:1243–1256, 2002
Lotan R: Is TIG1 a new tumor suppressor in prostate cancer? J Natl Cancer Inst
94:469–470, 2002
Luo LY, Rajpert-De Meyts ER, Jung K, Diamandis EP: Expression of the normal
epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor
gene in normal and malignant testicular tissue. Br J Cancer 85:220–224,
2001
Marshall D, Hardman MJ, Nield KM, Byrne C: Differentially expressed late con-
stituents of the epidermal cornified envelope. Proc Natl Acad Sci USA
98:13031–13036, 2001
Nagpal S, Patel S, Asano AT, Johnson AT, Duvic M, Chandraratna RA: Tazaro-
tene-induced gene 1 (TIG1), a novel retinoic acid receptor-responsive
gene in skin. J Invest Dermatol 106:269–274, 1996a
Nagpal S, Thacher SM, Patel S, et al: Negative regulation of two hyperprolifer-
ative keratinocyte differentiation markers by a retinoic acid receptor-spe-
cific retinoid: Insight into the mechanism of retinoid action in psoriasis.
Cell Growth Differ 7:1783–1791, 1996b
Nakashima K, Hagiwara T, Yamada M: Nuclear localization of peptidylarginine
deiminase V and histone deimination in granulocytes. J Biol Chem 277:
49562–49568, 2002
Nonomura K, Yamanishi K, Hosokawa Y, Doi H, Hirano J, Fukushima S, Yassuno
H: Localization of transglutaminase I mRNA in normal and psoriatic ep-
idermis by non-radioactive in situ hybridization. Br J Dermatol 128:23–28,
1993
Ohsawa T, Maruyama I, Senshu T: Collateral occurrence of deimination of kera-
tins with differentiation of an immortilized newborn rat keratinocyte cell
line cultured at air-liquid interface. J Dermatol Sci 19:68–73, 1999
Peng L, Malloy PJ, Feldman D: Identification of a functional vitamin D response
element in the human insulin-like growth factor binding protein-3 pro-
moter. Mol Endocrinol 18:1109–1119, 2004
Pinette KV, Yee YK, Amegadzie BY, Nagpal S: Vitamin D receptor as a drug
discovery target. Mini Rev Med Chem 3:193–204, 2003
Rachez C, Gamble M, Chang CPB, Atkins GB, Lazar MA, Freedman LP: The
DRIP complex and SRC-1/p160 coactivators share similar nuclear re-
ceptor binding determinants but constitute functionally distinct complex-
es. Mol Cell Biol 20:2718–2726, 2000
Rost T, Pyritz V, Rathcke IO, Gorogh T, Dunne AA, Werner JA: Reduction of LOX-
and LOXL2-mRNA expression in head and neck squamous cell carcino-
mas. Anticancer Res 23:1565–1573, 2003
Rots NY, Liu M, Anderson EC, Freedman LP: A differential screen for ligand-
regulated genes: Identification of HoxA10 as a target of vitamin D3 in-
duction in myeloid leukemic cells. Mol Cell Biol 18:1911–1918, 1998
Schmuth M, Elias PM, Hanley K, et al: The effect of LXR activators on AP-1
proteins in keratinocytes. J Invest Dermatol 123:41–48, 2004
Segre JA, Bauer C, Fuchs E: Klf4 is a transcription factor required for establishing
the barrier function of the skin. Nat Genet 22:356–360, 1999
Shridhar R, Zhang J, Song J, et al: Cystatin M suppresses the malignant phe-
notype of human MDA-MB-435S cells. Oncogene 23:2206–2215, 2004
Simon M, Jonca N, Guerrin M, et al: Refined characterization of corneodesmosin
proteolysis during terminal differentiation of human epidermis and its re-
lationship to desquamation. J Biol Chem 276:20292–20299, 2001
Smith EL, Pincus SH, Donovan L, Holick MF: A novel approach for the evaluation
and treatment of psoriasis. Oral or topical use of 1,25-dihydroxyvitamin
D3 can be a safe and effective therapy for psoriasis. J Am Acad Dermatol
19:516–528, 1988
Sotiropoulou G, Anisowicz A, Sager R: Identification, cloning, and characteriza-
tion of cystatin M, a novel cysteine proteinase inhibitor, down-regulated in
breast cancer. J Biol Chem 272:903–910, 1997
Suzuki Y, Koyama J, Moro O, Horii I, Kikuchi K, Tanida M, Tagami H: The role of
two endogenous proteases of the stratum corneum in degradation of
desmoglein-1 and their reduced activity in the skin of ichthyotic patients.
Br J Dermatol 134:460–464, 1996
Tarcsa E, Marekov LN, Mei G, Melino G, Lee SC, Steinert PM: Protein unfolding
by peptidylarginine deiminase: Substrate specificity and structural rela-
tionships of the natural substrates trichohyalin and filaggrin. J Biol Chem
271:30709–30716, 1996
Tezuka Y, Yonezawa S, Maruyama I, et al: Expression of thrombomodulin in es-
ophageal squamous cell carcinoma and its relationship to lymph node
metastasis. Cancer Res 55:4196–4200, 1995
Townsend MJ, Fallon PG, Matthews DJ, Jolin HE, McKenzie AN: T1/ST2-defi-
cient mice demonstrate the importance of T1/ST2 in developing primary T
helper cell type 2 responses. J Exp Med 191:1069–1076, 2000
Tse C, Xiang RH, Bracht T, Naylor SL: Human Semaphorin 3B (SEMA3B) located
at chromosome 3p21.3 suppresses tumor formation in an adenocarci-
noma cell line. Cancer Res 62:542–546, 2002
Welsh JB, Sapinoso LM, Su AI, et al: Analysis of gene expression identifies
candidate markers and pharmacological targets in prostate cancer. Can-
cer Res 61:5974–5978, 2001
Yousef GM, Yacoub GM, Polymeris ME, Popalis C, Soosaipillai A, Diamandis EP:
Kallikrein gene downregulation in breast cancer. Br J Cancer 90:167–172,
2004
Zeeuwen PL, Van Vlijmen-Willems IM, Jansen BJ, et al: Cystatin M/E expression
is restricted to differentiated epidermal keratinocytes and sweat glands: A
new skin-specific proteinase inhibitor that is a target for cross-linking by
transglutaminase. J Invest Dermatol 116:693–701, 2001
Zinser GM, Sundberg JP, Welsh J: Vitamin D(3) receptor ablation sensitizes skin to
chemically induced tumorigenesis. Carcinogenesis 23:2103–2109, 2002
VDR SIGNALING NETWORK IN KERATINOCYTES 785124 : 4 APRIL 2005
